Lung Cancer Screening and Approach to the Lung Nodule

Brigham and Women's Hospital

A. Ramaswamy

The Use of IO Doublet in PD-L1-Negative NSCLC

David Carbone

2024 Intervention Selection & Sequencing in Early Stage NSCLC

Total Health

J. Porter

Year in Review: Lung Cancer

Balazs Halmos

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

Cancer Screening Molecular Tools

Fengting Yan

Key to Successful Lung Cancer Screening and Lung Nodule Program

University of Colorado Department of Medicine

N. Thomas

WCLC 2024 Insights: Optimal Management of Malignant Pleural Effusion

Insights from 2024 WCLC

P. Lee

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

Staging Disease: How Oncologists Stage NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

Mediastinal Staging of Lung Cancer

MI&T Congressi

R. Trisolini

Lung Cancer Screening in Primary Care

UNC Lineberger Comprehensive Cancer Center

N. Robertson

The Role of Molecular Biomarkers for Lung Nodule Evaluation

Cleveland Clinic Respiratory Institute

P. J Mazzone

2024 Updates on the Fast-Changing NSCLC Landscape

Total Health

R. Osarogiagbon

NGS and Liquid Biopsy: Overcoming Challenges in Widespread Testing

Total Health

S. Kazmi

ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC

ecancer

E. Felip, A. Spira, A. Passaro, A. Addeo

The Evolving Role of Liquid Biopsy With a Focus on NSCLC, BC, and CRC

COR2ED The Heart of Medical Education

U. Malapelle

Approach to Adenopathy and Lung Nodules: A Case Based Discussion

Cleveland Clinic Respiratory Institute

S. Goel, G. Senyei

ADCs and Bispecific Inhibitors in NSCLC

Chul Kim